CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population (2011)
- Authors:
- USP affiliated authors: KRIEGER, JOSE EDUARDO - FM ; NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1186/1471-2350-12-13
- Subjects: POLIMORFISMO; GRUPOS ÉTNICOS; FENÓTIPOS; POPULAÇÃO; BRASIL
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Medical Genetics
- ISSN: 1471-2350
- Volume/Número/Paginação/Ano: v. 12, n. 13, p. (online), 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SANTOS, Paulo C. J. L. et al. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population. BMC Medical Genetics, v. 12, n. 13, p. (online), 2011Tradução . . Disponível em: https://doi.org/10.1186/1471-2350-12-13. Acesso em: 26 jan. 2026. -
APA
Santos, P. C. J. L., Soares, R. A. G., Santos, D. B. G., Krieger, J. E., Nicolau, J. C., Nascimento, R. M., et al. (2011). CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population. BMC Medical Genetics, 12( 13), (online). doi:10.1186/1471-2350-12-13 -
NLM
Santos PCJL, Soares RAG, Santos DBG, Krieger JE, Nicolau JC, Nascimento RM, Coelho GLLM, Mill JG, Pereira AC. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population [Internet]. BMC Medical Genetics. 2011 ; 12( 13): (online).[citado 2026 jan. 26 ] Available from: https://doi.org/10.1186/1471-2350-12-13 -
Vancouver
Santos PCJL, Soares RAG, Santos DBG, Krieger JE, Nicolau JC, Nascimento RM, Coelho GLLM, Mill JG, Pereira AC. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population [Internet]. BMC Medical Genetics. 2011 ; 12( 13): (online).[citado 2026 jan. 26 ] Available from: https://doi.org/10.1186/1471-2350-12-13 - P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction
- Doença arterial coronariana aguda
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Informações sobre o DOI: 10.1186/1471-2350-12-13 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
